Acrivon Therapeutics ACRV
NASDAQ ACRV
$1.76 -0.07 (-3.83%)
At close: Oct 22, 2026 · 4:00 PM EDT

Acrivon Therapeutics (ACRV) Price to Sales (2023 - 2026)

Updated

Analysis

Acrivon Therapeutics (ACRV) Price to Sales (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,145.84 Bn 1,114.43 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 501.86 Bn 474.97 Bn 12.70 Bn
4 Merck 356.87 Bn 311.24 Bn 12.21 Bn
5 Novartis Ag 301.53 Bn 265.52 Bn 11.24 Bn
6 Astrazeneca 264.97 Bn 238.66 Bn 12.86 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn
8 Gilead Sciences 195.50 Bn 169.70 Bn 6.22 Bn
9 Pfizer 171.60 Bn 118.24 Bn 10.94 Bn
10 Acrivon Therapeutics 72.55 Mn -362.99 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.57
Mar 31, 2026 9.84
Dec 31, 2025 11.77
Sep 30, 2025 7.52
Jun 30, 2025 4.26
Mar 31, 2025 6.53
Dec 31, 2024 20.43
Sep 30, 2024 25.55
Jun 30, 2024 23.63
Mar 31, 2024 24.24
Dec 31, 2023 15.75
API Access

Acrivon Therapeutics Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=ACRV&period=max&api_key=YOUR_API_KEY